VitaNova Life Sciences (VNOV) Income from Continuing Operations (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Income from Continuing Operations came in at 17549.0 in Q2 2026, down 97.81% YoY from 800332.0 in Q2 2025, and up 139.56% on a QoQ basis from 44362.0 in Q1 2026.
VitaNova Life Sciences (VNOV) Income from Continuing Operations (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 10 years of Income from Continuing Operations data on file, last reported at 17549.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 97.81% year-over-year to 17549.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 37304.0 (down 104.38% YoY) and the FY2026 annual result came in at 37304.0, down 104.38% from the prior year.
- Income from Continuing Operations climbed to 17549.0 in Q2 2026, from 44362.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 800332.0 in Q2 2025 to a low of 55211.0 in Q3 2024.
- A 5-year average of 50677.22 and a median of 2367.5 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations slumped 1236.22% — and 2024, when it surged 3929.4%.
- Tracing VNOV's Income from Continuing Operations over 5 years: stood at 2601.0 in 2022, then plunged by 436.6% to 8755.0 in 2023, then soared by 472.9% to 32647.0 in 2024, then grew by 9.69% to 35810.0 in 2025, then sank by 50.99% to 17549.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17549.0 (Q2 2026), 44362.0 (Q1 2026), and 35810.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.03 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 776.67 Mn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 400.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 103.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -14.41 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -89.07 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -3.87 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -6.09 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 17,549.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 17,549.00 |
| Jan 31, 2026 | -44,362.00 |
| Oct 31, 2025 | 35,810.00 |
| Jul 31, 2025 | -46,301.00 |
| Apr 30, 2025 | 800,332.00 |
| Jan 31, 2025 | 72,978.00 |
| Oct 31, 2024 | 32,647.00 |
| Jul 31, 2024 | -55,211.00 |
| Apr 30, 2024 | 167,919.00 |
| Jan 31, 2024 | 5,948.00 |
| Oct 31, 2023 | -8,755.00 |
| Jul 31, 2023 | -24,247.00 |
| Apr 30, 2023 | -4,385.00 |
| Jan 31, 2023 | -24,577.00 |
| Oct 31, 2022 | 2,601.00 |
| Jul 31, 2022 | 2,134.00 |
| Apr 30, 2022 | -26,807.00 |
| Jan 31, 2022 | 8,917.00 |
| Oct 31, 2021 | 15,009.00 |
| Jul 31, 2021 | 142,563.00 |